Catalyst Wire Dossier Catalyst Wire Dossier

RX-10100

· Rexahn Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RX-10100, covering 2009-05-05 to 2013-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder [Phase 2]

See pricing